Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists dig into old samples to predict myeloma return

NCT ID NCT07482761

Not yet recruiting Knowledge-focused Sponsor: BIWAKO Source: ClinicalTrials.gov ↗

First seen Mar 24, 2026 · Last updated May 25, 2026 · Updated 11 times

Summary

This study will check if stored tissue samples from 20 people with a specific type of multiple myeloma (t(4-14)) can be used to find new biomarkers linked to relapse. No new treatments or tests are given—researchers will only analyze samples already collected during routine care. The goal is to see if these archived samples are good enough for future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA AND MALIGNANT PLASMA CELL NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BIWAKO

    Lyon, 69006, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.